GAITHERSBURG, Md.--In a three-part deal Gene Logic has agreed to license NeuralStem BioPharmaceuticals' human central nervous system stem cell technology for gene expression analysis and for inclusion in Gene Logic's GeneExpress database. NeuralStem has bought a GeneExpress module and Gene Logic has made an equity investment in NeuralStem. Financial terms of the agreement were not disclosed.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.